It has been a mixed year for Merus N.V. insiders: $234.9 million bought by one person and $960,000 sold by one, so more buying than selling overall.
Biggest single buyer: GENMAB A/S, 10% Owner, with roughly $102.1 million.
No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | GENMAB A/S | 10% Owner | Buy | 1,052,806 | $97.00 | $102.1M | SEC |
| Dec 30, 2025 | GENMAB A/S | 10% Owner | Buy | 2,978 | $97.00 | $289K | SEC |
| Dec 29, 2025 | GENMAB A/S | 10% Owner | Buy | 15,710 | $97.00 | $1.5M | SEC |
| Dec 29, 2025 | GENMAB A/S | 10% Owner | Buy | 96,082 | $97.00 | $9.3M | SEC |
| Dec 29, 2025 | GENMAB A/S | 10% Owner | Buy | 142,610 | $97.00 | $13.8M | SEC |
| Dec 29, 2025 | GENMAB A/S | 10% Owner | Buy | 561,042 | $97.00 | $54.4M | SEC |
| Dec 22, 2025 | GENMAB A/S | 10% Owner | Buy | 212,177 | $97.00 | $20.6M | SEC |
| Dec 22, 2025 | GENMAB A/S | 10% Owner | Buy | 66,264 | $97.00 | $6.4M | SEC |
| Dec 18, 2025 | GENMAB A/S | 10% Owner | Buy | 150,795 | $97.00 | $14.6M | SEC |
| Dec 18, 2025 | GENMAB A/S | 10% Owner | Buy | 120,752 | $97.00 | $11.7M | SEC |
| Dec 10, 2025 | Shuman Harry | Officer | Sell | 1,700 | $96.10 | $163K | SEC |
| Nov 28, 2025 | Shuman Harry | Officer | Sell | 8,300 | $95.92 | $796K | SEC |
| Jul 18, 2025 | Silverman Peter B. | COO | Sell | 25,000 | $60.00 | $1.5M | SEC |
| Jul 11, 2025 | Silverman Peter B. | COO | Sell | 6,695 | $55.00 | $368K | SEC |
| Jul 11, 2025 | Silverman Peter B. | COO | Sell | 16,805 | $55.00 | $924K | SEC |
In the last 12 months Merus N.V. insiders made open-market purchases worth about $234.9 million and sales worth about $960,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MRUS was filed on 2025-12-30.
No congressional trades in MRUS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).